用于治疗用途的蛋白C缩物.

Study of complement-mediated anaphylaxis in humans. The role of IgG subclasses (IgG1 and/or IgG4) in the complement-activating capacity of immune complexes.

Journal of immunology (Baltimore, Md. : 1950)·1996

Activation of the hemostatic mechanism during thrombolysis in patients with unstable angina pectoris.

Blood·1995

Determinants of plasma factor VIIa levels in humans.

Blood·1995

Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors.

British journal of haematology·1995

Heightened thrombin formation but normal plasma levels of activated factor VII in patients with acute coronary syndromes.

Arteriosclerosis, thrombosis, and vascular biology·1995

Platelet von Willebrand factor abnormalities in myeloproliferative syndromes.

American journal of hematology·1995

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Quantification and mitigation of system background fluorescence in fiber-optic-based imaging systems.

Biomedical optics express·2026

Exploring the Value of Functional Magnetic Resonance Imaging in Assessing Subclinical Rejection in Kidney Transplantation.

Kidney diseases (Basel, Switzerland)·2026

Robot-assisted laparoscopic resection of giant pelvic solitary fibrous tumor: a case report with literature review.

Frontiers in oncology·2026

The role and therapeutic potential of nanotechnology-mediated ferroptosis regulation in myelodysplastic syndromes.

Frontiers in oncology·2026

An ATPγS recycling strategy for practical biocatalytic thiophosphorylation.

Nature·2026

Retinoic acid- and TGF-β1-preconditioned hBM-MSCs show distinct reparative profiles after transplantation in Busulfan-induced testicular injury.

Scientific reports·2026

相关实验视频

用于治疗用途的蛋白C缩物

相关概念视频

Study of complement-mediated anaphylaxis in humans. The role of IgG subclasses (IgG1 and/or IgG4) in the complement-activating capacity of immune complexes.

Activation of the hemostatic mechanism during thrombolysis in patients with unstable angina pectoris.

Determinants of plasma factor VIIa levels in humans.

Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors.

Heightened thrombin formation but normal plasma levels of activated factor VII in patients with acute coronary syndromes.

Platelet von Willebrand factor abnormalities in myeloproliferative syndromes.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Quantification and mitigation of system background fluorescence in fiber-optic-based imaging systems.

Exploring the Value of Functional Magnetic Resonance Imaging in Assessing Subclinical Rejection in Kidney Transplantation.

Robot-assisted laparoscopic resection of giant pelvic solitary fibrous tumor: a case report with literature review.

The role and therapeutic potential of nanotechnology-mediated ferroptosis regulation in myelodysplastic syndromes.

An ATPγS recycling strategy for practical biocatalytic thiophosphorylation.

Retinoic acid- and TGF-β1-preconditioned hBM-MSCs show distinct reparative profiles after transplantation in Busulfan-induced testicular injury.

相关实验视频

用于治疗用途的蛋白C缩物

相关概念视频

相关文章